Research of Biomarkers in Duchenne Muscular Dystrophy Patients

NCT01380964 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2016-08-17

No results posted yet for this study

Summary

The purpose of this study is to identify potential biomarkers for the diagnosis, disease progression assessment and response to treatment in patients with Duchenne Muscular Dystrophy.

Conditions

  • Duchenne Muscular Dystrophy (DMD)

Sponsors & Collaborators

  • Institute of Myology

    collaborator OTHER
  • Genethon

    lead OTHER

Principal Investigators

  • Laurent SERVAIS, MD · Myology Institute

Eligibility

Min Age
3 Years
Max Age
20 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01380964 on ClinicalTrials.gov